FDA Approval of Zolgensma, first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), has become a milestone in the treatment of patients with SMA. It ...
According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth ...
Christopher Wood of Jefferies holds a bullish outlook on Bitcoin, maintaining a 10% allocation in his portfolio. He plans to take profits at $150,000, citing historical trends and favourable ...